Bravo Dalibel, Wagner Eric R, Larson Dirk R, Davis Mark P, Pagnano Mark W, Sierra Rafael J
Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota; Department of Pediatric Infectious Disease, Mayo Clinic, Rochester, Minnesota; Department of Orthopedic Surgery, NYU Hospital for Joint Diseases, New York, New York.
Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota; Department of Pediatric Infectious Disease, Mayo Clinic, Rochester, Minnesota.
J Arthroplasty. 2016 Aug;31(8):1717-21. doi: 10.1016/j.arth.2016.01.024. Epub 2016 Jan 21.
It is unclear whether a positive skin patch test for metal allergy in patients with skin hypersensitivity to metals is associated with an increased risk of total knee arthroplasty (TKA) failure. Our aim was to determine whether patients with a history of metal allergy who had a positive skin patch test (SPT+) had worse outcomes after primary TKA compared with those with a negative skin patch test and compared with controls.
Over 12 years, 127 patients underwent 161 TKA after skin patch testing (SPT; 56 were positive). Cases were matched by age, gender, body mass index, American Society of Anesthesiologists score, implant type, and implant manufacturer to 161 control knee arthroplasties without any prior history of metal allergy and no SPT. Median follow-up was 5.3 years. Differences in outcome measures were assessed between groups.
Patients with a SPT+ to metal did not have a higher complication, reoperation, or revision rates compared with patients with a SPT- and matched controls. Survivorship free of revision at 5 years was 98.1% for SPT+; 100% for SPT-; 97.6% for SPT+ controls, 99.0% for SPT- controls. There was no statistically significant difference in postoperative pain between SPT+ and SPT- patients and matched controls.
This study was designed to evaluate the effect of metal hypersensitivity on TKA outcomes and the role of SPT in patients before TKA. In this study, a SPT+ for metals was of little practical value in predicting the midterm outcome after TKA and cannot be strongly recommended as a method to guide the selection of implant type.
对于金属皮肤过敏的皮肤超敏患者,金属过敏的阳性皮肤斑贴试验是否与全膝关节置换术(TKA)失败风险增加相关尚不清楚。我们的目的是确定有金属过敏史且皮肤斑贴试验阳性(SPT+)的患者与皮肤斑贴试验阴性的患者以及对照组相比,初次TKA后是否有更差的结果。
在12年期间,127例患者在进行皮肤斑贴试验(SPT;56例为阳性)后接受了161次TKA。病例根据年龄、性别、体重指数、美国麻醉医师协会评分、植入物类型和植入物制造商与161例无任何金属过敏史且未进行SPT的对照膝关节置换术进行匹配。中位随访时间为5.3年。评估组间结局指标的差异。
与SPT阴性的患者和匹配的对照组相比,金属SPT+的患者没有更高的并发症、再次手术或翻修率。SPT+组5年无翻修的生存率为98.1%;SPT-组为100%;SPT+对照组为97.6%,SPT-对照组为99.0%。SPT+和SPT-患者及匹配对照组之间术后疼痛无统计学显著差异。
本研究旨在评估金属超敏反应对TKA结局的影响以及SPT在TKA术前患者中的作用。在本研究中,金属SPT+在预测TKA中期结局方面几乎没有实际价值,不能强烈推荐作为指导植入物类型选择的方法。